-+ 0.00%
-+ 0.00%
-+ 0.00%

CADRENAL THERAPEUTICS - NO SERIOUS ADVERSE EVENTS OR DEATHS REPORTED WITH CAD-1005 IN PHASE 2 TRIAL

路透·07/13/2026 13:01:03

登录查看新闻详情